Glancing at the upcoming events, this was the only one that looked like it would have a significant effect on the stock price:
By end 2007 -- Kuvan approval decision by FDA
Since you are buying right now, do you think BIOM is just undervalued right now and is due for a rebound, or do you see other price drivers for the stock?
Market Data 
Markets 
AI
